Chesnara Plc: Fourth acquisition in two years
12 November 2026
Zai Lab Limited (NASDAQ: ZLAB), a leading player in the biotechnology sector, is capturing investor attention with a remarkable potential upside of 47.36%. Headquartered in Shanghai,..
Alvotech (NASDAQ: ALVO), a Luxembourg-based pharmaceutical company specializing in biosimilar medicines, is capturing the attention of investors with a compelling potential upside of 69.33%. Operating in..
MoonLake Immunotherapeutics (NASDAQ: MLTX) is carving out a strong niche in the biotechnology sector, commanding attention with its innovative approaches to treating inflammatory skin and joint..
Alignment Healthcare, Inc. (NASDAQ: ALHC) stands out in the competitive healthcare sector, specifically within the niche of Medicare Advantage plans targeting seniors. Headquartered in Orange, California,..
Investors focusing on biotechnology stocks should take a closer look at PTC Therapeutics, Inc. (NASDAQ: PTCT), a company that is making significant strides in the healthcare..
NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a pioneering entity in the biotechnology sector, is capturing investor attention with its impressive growth trajectory and substantial upside potential...
Individual investors with a keen eye on the biotechnology sector may find Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) an intriguing prospect, particularly given its potential for substantial..
LivaNova PLC (LIVN) stands at the forefront of the medical device industry, carving out a niche with its innovative solutions for neurological and cardiac conditions. Headquartered..
As investors navigate the ever-evolving landscape of the biotechnology sector, Vericel Corporation (NASDAQ: VCEL) stands out with a compelling potential upside of 35.5%. This Cambridge, Massachusetts-based..
Perrigo Company plc (NYSE: PRGO), a prominent player in the healthcare sector, has captured investor attention with its significant potential upside. The company, headquartered in Dublin,..
As the healthcare sector continues to captivate investor interest, ImmunityBio, Inc. (NASDAQ: IBRX) stands out with a market cap of $3.04 billion and a compelling 231.40%..
Concentra Group Holdings Parent, Inc. (CON) stands as a compelling player in the healthcare sector, specifically within the medical care facilities industry. Based in Addison, Texas,..
Haemonetics Corporation (NYSE: HAE), a key player in the healthcare sector specializing in medical devices, presents a compelling investment case for individual investors. With a current..
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) has been capturing the attention of investors with its recent performance in the biotechnology sector, particularly with an enticing potential upside..
Soleno Therapeutics, Inc. (NASDAQ: SLNO), a clinical-stage biopharmaceutical company, is capturing investor attention with its promising potential upside of 47%. As it stands, the company is..
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a pioneering force in the biotechnology sector, presents an intriguing investment opportunity for those with an appetite for innovation-driven growth. With..
For investors keen on exploring opportunities within the biotechnology sector, Akero Therapeutics, Inc. (NASDAQ: AKRO) presents a compelling case. With a market capitalization of $4.33 billion,..
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is making waves in the biotechnology sector with its focus on rare neuroendocrine diseases. The company’s lead product, IMCIVREE (setmelanotide), is..
Krystal Biotech, Inc. (KRYS), a burgeoning player in the biotechnology sector, is steadily carving a niche for itself by focusing on genetic medicines designed to address..
Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector specializing in drug manufacturing, has recently attracted attention from investors due to a promising potential..
